Biologics Is Fastest Growing Segment Fueling The Growth Of Calcineurin Inhibitor Market

 Calcineurin Inhibitor Market


The global Calcineurin Inhibitor Market is estimated to be valued at US$ 10.07 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Calcineurin inhibitors are immunosuppressants that help prevent organ transplant rejection by suppressing T-cell activation. They act by inhibiting the action of calcineurin, an enzyme involved in signaling pathways of T-cell activation. Calcineurin inhibitors find application in transplantation procedures such as kidney, heart and liver transplantation.

Market Key Trends:
One of the key trends in the calcineurin inhibitor market is the increasing preference towards biologics. Biologics act as potent and specific alternatives to first generation immunosuppressants with lesser side effects. For instance, belatacept, a selective T-cell costimulation blocker, demonstrated superior long-term kidney function compared to calcineurin inhibitors in renal transplant recipients. Rising awareness about advantages of biologics and their approval for wider clinical indications is expected to drive their demand, replacing conventional calcineurin inhibitors to a certain extent in the coming years.


Segment Analysis
The calcineurin inhibitor market is dominated by the cyclosporine segment. Cyclosporine is one of the oldest and most commonly prescribed calcineurin inhibitors. It is mostly used for the prevention of organ transplant rejection during kidney, heart, and liver transplantations. The segment held around 60% of the global market share in 2023 owing to the wide acceptance and availability of generic forms of cyclosporine.

Key Takeaways
The Global Calcineurin Inhibitor Market Demand is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to an increasing number of organ transplantation surgeries globally.

Regional analysis
North America dominated the global calcineurin inhibitor market and accounted for over 30% of the global market share in 2023. This is attributed to factors such as the presence of developed healthcare infrastructure, high adoption of innovative transplantation drugs, and favorable government programs. Asia Pacific is anticipated to be the fastest-growing region during the forecast period owing to rising awareness about transplantation and increasing healthcare spending in major APAC countries.

Key players
Key players operating in the calcineurin inhibitor market are Novartis AG, Astellas Pharma Inc., LEO Pharma A/S, Allergan, Inc., Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Roche Holding AG, Bristol Myers Squibb Company, AbbVie Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Mylan N.V. Novartis, with its generic version of cyclosporine, dominates the market.

Read More:

Comments

Post a Comment

Popular posts from this blog

Electronic Warfare Market Poised to Witness High Growth Owing to Increasing Usage of EW Systems Across Military and Defense Sectors

Image
Electronic Warfare Market Electronic warfare (EW) systems are used for detecting, deceiving or damaging enemy’s communication and radar systems. It involves deliberate emission or suppression of electromagnetic energy to maintain information dominance. EW systems find wide applications across military, including land, sea, air and space operations for counteracting threats from armed forces of other nations. The need for situational awareness and gaining tactical advantage over opponents has catalyzed demand from armed forces globally. The global electronic warfare market is estimated to be valued at US$ 18.45 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031.  Key players operating in the electronic warfare market are BAE Systems plc, Elbit Systems Ltd., General Dynamics Corporation, Israel Aerospace Industries Ltd., L3Harris Technologies Inc., Leonardo SpA, Lockheed Martin Corporation, Northrop Grumman Corporation, Raytheon Technologies Corpor
Read more

Cellulose Films is the largest segment driving the growth of Cellulose Plastics Market

Image
  Cellulose Plastics Market The global Cellulose Plastics Market is estimated to be valued at US$ 819.69 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Cellulose plastics are bioplastics made from cellulose, one of the most abundant organic polymer on Earth. They are produced from plant materials like wood and agricultural residues. Cellulose plastics offer advantages like biodegradability, recyclability and sustainability. They are widely used in agriculture films, food packaging and textiles. Market key trends: One of the key trend in the cellulose plastics market is growing demand for biodegradable and sustainable packaging solutions. Rising environmental concerns regarding widespread use of conventional plastics is driving the demand for eco-friendly cellulose plastics. Strict government regulations prohibiting use of single use plast
Read more

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

Image
  Eyewear Market The global Eyewear Market is estimated to be valued at US$ 273.4 billion in 2018 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: The Eyewear Market includes products such as prescription glasses, contact lenses, and sunglasses. These products offer vision correction and protection from harmful ultraviolet (UV) rays. The increasing prevalence of eye disorders and the growing awareness about the importance of eye health are driving the demand for eyewear products. Furthermore, the rising use of digital devices and exposure to blue light is also contributing to the need for prescription eyewear to reduce eye strain and prevent vision problems. Market Key Trends: One key trend in the Eyewear Market is the increasing demand for fashionable and luxury eyewear. Consumers are not only seeking vision correction but also looking for eyewear that complements
Read more